J. Takamatsu

发表

Clinical protocol for angiogenesis by intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe coronary artery disease: TACT-NAGOYA-HEART.

T. Naoe, T. Kato, H. Izawa, 2006, Circulation journal : official journal of the Japanese Circulation Society.

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

J. Takamatsu, M. Taneichi, A. Shirahata, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Three Distinct Point Mutations in the Factor IX Gene of Three Japanese CRM+ Hemophilia B Patients (Factor IX BMNagoya 2, Factor IX Nagoya 3 and 4)

H. Saito, M. Tanimoto, J. Takamatsu, 1991, Thrombosis and Haemostasis.

α2-PLASMIN-INHIBITOR DEFICIENCY (MIYASATO DISEASE)

J. Takamatsu, K. Ogata, T. Kamiya, 1978, The Lancet.

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.

K Fukutake, H. Saito, Y. Takebe, 1999, Proceedings of the National Academy of Sciences of the United States of America.

A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene.

J. Takamatsu, T. Matsushita, I. Sugiura, 1993, Thrombosis research.

L1503R is a member of group I mutation and has dominant‐negative effect on secretion of full‐length VWF multimers: an analysis of two patients with type 2A von Willebrand disease

T. Naoe, T. Murate, J. Takamatsu, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.

J. Takamatsu, T. Hayakawa, Y. Katano, 2000, Blood.

Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis.

E. Davie, I. Maruyama, J. Takamatsu, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Phase I/II trial of didanosine (2',3'-dideoxyinosine) in hemophiliac patients with AIDS or AIDS-related complex.

J. Takamatsu, K. Fukutake, J. Mimaya, 1993, Clinical and diagnostic virology.

Rapid Communication Molecular Evaluation of Endothelial Progenitor Cells in Patients with Ischemic Limbs Therapeutic Effect by Stem Cell Transplantation Vascular Biology

T. Naoe, H. Izawa, K. Komori, 2022 .

Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.

T. Naoe, H. Izawa, K. Komori, 2007, Circulation journal : official journal of the Japanese Circulation Society.

therapy virus and human immunodeficiency virus: influence of antiretroviral Immunologic dynamics in hemophiliac patients infected with hepatitis C

H. Toyoda, J. Takamatsu, T. Hayakawa, 2013 .

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

Koji Yamamoto, J. Takamatsu, H. Saito, 2005, Cardiovascular research.

A long‐term follow‐up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders

K. Isobe, J. Takamatsu, T. Hayakawa, 1996, European journal of haematology.

Anti‐HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin

T. Honda, J. Takamatsu, T. Matsushita, 2006, Journal of thrombosis and haemostasis : JTH.

Hepatic histopathologic range compared with virological studies of hepatitis viruses among autopsy cases in Tokyo.

M. Okudaira, J. Takamatsu, S. Tokudome, 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo.

Koji Yamamoto, J. Takamatsu, T. Kojima, 2009, Thrombosis research.

Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.

K. Hayashi, H. Goto, T. Honda, 2005, JAMA.

Comparison of the efficacy of ribavirin plus peginterferon alfa‐2b for chronic hepatitis C infection in patients with and without coagulation disorders

K. Hayashi, Y. Hirooka, H. Goto, 2013, Journal of medical virology.

Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor: A Case Report and Review of the Literature

T. Naoe, Koji Yamamoto, J. Takamatsu, 2006, International journal of hematology.

Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan: a retrospective multicenter analysis

K. Chayama, K. Koike, J. Takamatsu, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Chronic hepatitis C in patients co‐infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis

K. Chayama, K. Koike, J. Takamatsu, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Prevalence of hepatitis B virus infection in Japanese patients with HIV

K. Koike, J. Takamatsu, T. Tsutsumi, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Pregnancy complicated by idiopathic thrombocytopenic purpura

T. Terao, J. Takamatsu, T. Kamiya, 1981 .

Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes

H. Toyoda, J. Takamatsu, T. Hayakawa, 1999, American Journal of Gastroenterology.

Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1996, Blood.

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII–FS) in patients with haemophilia A: a long‐term, multicentre clinical study in Japan

J. Takamatsu, A. Shirahata, M. Shima, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

A Comparative Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation

J. Takamatsu, K. Takatsuki, N. Ogawa, 2002, International journal of hematology.

Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474.

J. Takamatsu, M. Hamaguchi, I. Sugiura, 1996, Blood.

Intravenous Immunoglobulin Therapy for Acquired Coagulation Inhibitors: A Critical Review

Koji Yamamoto, J. Takamatsu, H. Saito, 2007, International journal of hematology.

FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line.

H. Saito, M. Ogura, J. Takamatsu, 1991, Blood.

Novel Deletion and Insertion Mutations Cause Splicing Defects, Leading to Severe Reduction in mRNA Levels of the A Subunit in Severe Factor XIII Deficiency

T. Saito, J. Takamatsu, H. Saito, 1998, Thrombosis and Haemostasis.

Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Recurrent Mutations of Factor XI Gene in Japanese

T. Murate, Koji Yamamoto, J. Takamatsu, 2006, International journal of hematology.

Arg260‐Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics

J. Takamatsu, H. Umeyama, H. Saito, 1998, British journal of haematology.

Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.

H. Saito, T. Terao, J. Takamatsu, 1990, Gynecologic and obstetric investigation.

Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial

Y. Ohashi, J. Takamatsu, A. Shirahata, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors

S. Fujita, J. Takamatsu, J. Kamizono, 2001, International journal of hematology.

Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).

J. Takamatsu, H. Saito, M. Hamaguchi, 1989, Biochimica et biophysica acta.

Clearance of hepatitis G viremia in a human immunodeficiency virus-positive patient by high-activity antiretroviral therapy.

J. Takamatsu, Y. Fukuda, H. Toyoda, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interferon treatment of two patients with quadruple infection with hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis G virus (HGV), and TT virus (TTV).

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1999, Liver.

Genotype establishments for protein C deficiency by use of a DNA polymorphism in the gene.

M. Tanimoto, J. Takamatsu, H. Saito, 1991, Blood.

Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis

Y. Toyama, J. Mimuro, J. Takamatsu, 2011 .

A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Y. Ohashi, J. Takamatsu, H. Mugishima, 2013, Haemophilia.

Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report

Y. Ohashi, J. Takamatsu, A. Shirahata, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1997, Journal of hepatology.

Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV‐C/HGV) RNA and those with GBV‐C/HGV E2‐antibody in patients with hemophilia

H. Toyoda, J. Takamatsu, T. Hayakawa, 2000 .

Simultaneous determination of platelet life-span by isotopic (51Cr-labeling) and non-isotopic (Aspirin-loading) methods in patients with thrombocythemia

J. Takamatsu, K. Ogata, T. Kamiya, 1980 .

THERAPEUTIC ANGIOGENESIS BY BONE MARROW MONONUCLEAR CELL TRANSPLANTATION AND QUANTITATIVE EVALUATION OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH PERIPHERAL OBSTRUCTIVE ARTERIAL DISEASE

K. Komori, T. Murohara, T. Kondo, 2005 .

Life‐threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor‐1 deficiency in humans

T. Terao, J. Takamatsu, N. Kanayama, 2011, Journal of thrombosis and haemostasis : JTH.

Massive bleeding from a gastric erosion after transcatheter arterial chemoembolization for hepatocellular carcinoma in a patient with mild haemophilia A

J. Takamatsu, T. Hayakawa, Y. Fukuda, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Diversity of Nucleotide Sequences in Hypervariable Region 1 of Hepatitis C Virus in Japanese Patients with Chronic Hepatitis C of Unknown Mode of Transmission

H. Toyoda, J. Takamatsu, T. Hayakawa, 1999, Digestive Diseases and Sciences.

Characteristics of patients with chronic infection due to hepatitis C virus of mixed subtype: prevalence, viral RNA concentrations, and response to interferon therapy.

J. Takamatsu, T. Hayakawa, T. Takayama, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes

J. Takamatsu, T. Hayakawa, T. Takayama, 1998, Journal of medical virology.

Hepatitis C virus infection and genotypes in Japanese hemophiliacs.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 2008, Liver.

Infection of hepatitis A virus in Japanese haemophiliacs.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 2001, The Journal of infection.

Comparative studies on the structures of the carbohydrate moieties of human fibrinogen and abnormal fibrinogen Nagoya.

J. Takamatsu, S. Iwanaga, A. Kobata, 1982, Journal of Biochemistry (Tokyo).

Effects of antibody to VIII R: Ag in the plasma of a multitransfused patient with von Willebrand's disease on platelet-related functions of F VIII

J. Takamatsu, K. Ogata, T. Kamiya, 1983 .

EFFICACY OF AUTOLOGOUS FRESH PLATELET CONCENTRATE HARVESTED BY PLASMAPHERESIS IN THORACIC AORTIC ANEURYSM SURGERY

A. Usui, J. Takamatsu, Y. Ueda, 2008 .

Effects of recombinant human erythropoietin on thrombosis and fibrinolysis in autologous transfusion for hip surgery

H. Iwata, J. Takamatsu, Y. Hasegawa, 1999, Archives of Orthopaedic and Trauma Surgery.

Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600----Thr replacement found in plasmin light chain variants.

Y. Sakata, J. Takamatsu, S. Iwanaga, 1984, Journal of biochemistry.

Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation

T. Naoe, M. Tanimoto, R. Ueda, 1999, Bone Marrow Transplantation.

Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV‐positive patients with haemophilia

J. Takamatsu, Y. Fukuda, K. Hayashi, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Enhanced expression of thrombomodulin by intracellular cyclic AMP-increasing agents in two human megakaryoblastic leukemia cell lines.

M. Ogura, S. Yamamoto, T. Ito, 1990, Thrombosis research.

A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2008 .

Rapidly destructive arthropathy of the hip in haemophilia

J. Takamatsu, N. Ishiguro, H. Iwata, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Rapidly destructive arthropathy of the hip in haemophilia.

J. Takamatsu, N. Ishiguro, H. Iwata, 2001 .

Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2019, International Journal of Hematology.

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Localization and Biosynthesis of Functional Thrombomodulin in Human Megakaryocytes and a Human Megakaryoblastic Cell Line (MEG-01)

H. Saito, M. Ogura, S. Yamamoto, 1990, Thrombosis and Haemostasis.

Identification of the thrombin receptor on human platelets by chemical crosslinking.

H. Gralnick, J. Takamatsu, M. Horne, 1986, The Journal of clinical investigation.

Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Treatment for abdominal aortic aneurysm in a patient with hemophilia A: a case report and review of the literature.

Y. Nimura, J. Takamatsu, M. Matsushita, 1997, Journal of vascular surgery.

Clinical Evaluation of a Recombinant Factor VIII Preparation (Kogenate) in Previously Untreated Patients with Hemophilia A

J. Takamatsu, A. Shirahata, K. Fukutake, 2003 .

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Y. Ohashi, J. Takamatsu, H. Mugishima, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Study of Recombinant Factor VIIa (NN-007) in Hemophilia Patients with Inhibitors

J. Takamatsu, H. Saito, A. Shirahata, 1994 .

Multicenter Clinical Study of a Highly Purified Porcine Factor VIII Concentrate [MTI-9002 (Hyate: C)] in Hemophilia A Patients with Inhibitor

J. Takamatsu, H. Saito, A. Shirahata, 1991 .

Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.

J. Takamatsu, H. Saito, I. Takahashi, 1991, The Journal of laboratory and clinical medicine.

Blood clotting factor IX BM Nagoya. Substitution of arginine 180 by tryptophan and its activation by alpha-chymotrypsin and rat mast cell chymase.

J. Takamatsu, S. Kawabata, H. Saito, 1989, The Journal of biological chemistry.

Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2)

J. Takamatsu, S. Ohga, Masao Kobayashi, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Evaluation of Recombinant Factor VIII Preparation (Kogenate) in Previously Treated Patients with Hemophilia A: Descriptive Meta-Analysis of Post-Marketing Study Data

J. Takamatsu, A. Shirahata, K. Fukutake, 2006, International journal of hematology.

DNA analysis of seven patients with hemophilia B who have anti-factor IX antibodies: relationship to clinical manifestations and evidence that the abnormal gene was inherited.

K. Kurachi, M. Tanimoto, Y. Obata, 1988, The Journal of laboratory and clinical medicine.

Carrier detection in Japanese hemophilia A by use of three intragenic and two extragenic factor VIII DNA probes: a study of 24 kindreds.

H. Saito, M. Tanimoto, J. Takamatsu, 1988, The Journal of laboratory and clinical medicine.

Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia A.

J. Takamatsu, A. Shirahata, M. Shima, 2000, International journal of hematology.

Epitope mapping of human factor IX inhibitor antibodies

J. Takamatsu, H. Saito, I. Takahashi, 1994, British journal of haematology.

Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation

T. Naoe, T. Murate, Koji Yamamoto, 2010, International journal of hematology.

Normal function levels of protein C inhibitor in two groups with different inheritance modes of congenital combined factor V/VIII deficiency

J. Nishioka, Koji Suzuki, J. Takamatsu, 1984 .

Safety and complications of interventional radiology for hepatocellular carcinoma in patients with haemophilia and cirrhosis

J. Takamatsu, Y. Fukuda, K. Hayashi, 2001, British journal of haematology.

Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus‐infected haemophiliacs

J. Takamatsu, T. Hayakawa, Y. Fukuda, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Three Distinct Candidate Point Mutations of the von Willebrand Factor Gene in Four Patients with Type IIA von Willebrand Disease

H. Saito, M. Tanimoto, Koji Yamamoto, 1992, Thrombosis and Haemostasis.

Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan

K. Hayashi, H. Goto, T. Honda, 2004, Journal of medical virology.

Assessment and treatment of liver disease in Japanese haemophilia patients

C. Kessler, J. Takamatsu, T. Hayakawa, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Infection with GB virus C, hepatitis C and B viruses in 1,044 cases autopsied at the medical examiner's office in Tokyo

F Tsuda, M. Okudaira, J. Takamatsu, 1998, Journal of medical virology.

Prevalence of Hepatitis E Virus IgG Antibody in Japanese Patients with Hemophilia

K. Hayashi, H. Goto, T. Honda, 2008, Intervirology.

Prevalence of drug resistance-related mutations among HIV-1s in Japan.

S. Kashiwagi, W. Sugiura, J. Takamatsu, 1999, Japanese journal of infectious diseases.

Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency.

H. Saito, M. Tanimoto, Koji Yamamoto, 1992, The Journal of clinical investigation.

Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.

J. Takamatsu, N. Emi, H. Saito, 1993, Thrombosis research.

Antithrombotic and Anticoagulant Activity of Depolymerized Fragment of the Glycosaminoglycan Extracted from Stichopus japonicus Selenka

J. Takamatsu, K. Kitazato, N. Suzuki, 1991, Thrombosis and Haemostasis.

Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer.

J. Takamatsu, S. Iwanaga, H. Saito, 1989, Journal of biochemistry.

Identification of protein Sα gene mutations including four novel mutations in eight unrelated patients with protein S deficiency

T. Murate, Koji Yamamoto, J. Takamatsu, 2004 .

Alpha2-plasmin-inhibitor deficiency (Miyasato disease).

J. Takamatsu, K. Ogata, T. Kamiya, 1978, Lancet.

Congenital Protein C Deficiency Combined with a Congenital Abnormal Plasminogen with Deep Venous Thrombosis

J. Takamatsu, K. Kagami, T. Sakurai, 1991 .

A Novel Nonsense Mutation Associated with an Exon Skipping in a Patient with Hereditary Protein S Deficiency Type I

H. Saito, J. Takamatsu, Y. Okamoto, 1996, Thrombosis and Haemostasis.

A novel splice site mutation in intron C of PROS1 leads to markedly reduced mutant mRNA level, absence of thrombin-sensitive region, and impaired secretion and cofactor activity of mutant protein S.

Koji Yamamoto, J. Takamatsu, H. Saito, 2010, Thrombosis research.

In vitro characterization of missense mutations associated with quantitative protein S deficiency

T. Naoe, T. Murate, J. Takamatsu, 2006, Journal of thrombosis and haemostasis : JTH.

DNA sequence analysis of protein S deficiency--identification of four point mutations in twelve Japanese subjects.

Y. Yamamoto, J. Takamatsu, N. Kanayama, 2001, Seminars in thrombosis and hemostasis.

A Quantitative Protein S Deficiency Associated with a Novel Nonsense Mutation and Markedly Reduced Levels of Mutated mRNA

H. Saito, J. Takamatsu, M. Hamaguchi, 1995, Thrombosis and Haemostasis.

β-thromboglobulin (β-TG) and platelet factor 4 (Pf-4) levels in various cardiovascular diseases

J. Takamatsu, T. Kamiya, K. Koie, 1981 .

TT virus genotype changes frequently in multiply transfused patients with hemophilia but rarely in patients with chronic hepatitis C and in healthy subjects

J. Takamatsu, Koji Suzuki, Y. Katano, 2001, Transfusion.

Infection with TT virus, a novel transfusion‐transmissible DNA virus, in haemophiliacs and in blood products

J. Takamatsu, T. Hayakawa, Y. Katano, 1999, British journal of haematology.

Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers.

K. Hayashi, H. Toyoda, J. Takamatsu, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

GB Virus C/Hepatitis G Virus Isolates in Japanese Haemophiliacs and their Origins

J. Takamatsu, T. Hayakawa, H. Okamoto, 1998, Thrombosis and Haemostasis.

Evaluation of a new assay for hepatitis C virus genotyping and viral load determination in patients with chronic hepatitis C.

K. Hayashi, H. Toyoda, J. Takamatsu, 2002, Journal of virological methods.

Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia

H. Goto, T. Honda, J. Takamatsu, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Effect of Coinfection With Hepatitis G Virus on HIV Disease Progression in Hemophilic Men

H. Toyoda, J. Takamatsu, T. Hayakawa, 1998 .

Cumulative Fraction of Patients with AIDS among Japanese Hemophiliacs Infected with HIV-1.

S. Tatsunami, J. Takamatsu, A. Shirahata, 1999 .

Obesity enhances the induction of plasminogen activator inhibitor‐1 by restraint stress: a possible mechanism of stress‐induced renal fibrin deposition in obese mice

M. Hayashi, D. Loskutoff, J. Takamatsu, 2005, Journal of thrombosis and haemostasis : JTH.

Observed decline in the rate of death among Japanese hemophiliacs infected with HIV-1.

S. Tatsunami, J. Takamatsu, A. Shirahata, 2000, International journal of hematology.

[Causes of death (1983-1997) in patients infected with human immunodeficiency virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection].

S. Tatsunami, J. Takamatsu, A. Shirahata, 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology.

A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.

Y. Matsuzawa, S. Honda, Y. Tomiyama, 1998, The Journal of clinical investigation.

A patient of short stature with idiopathic hypoparathyroidism round face and metacarpal signs.

J. Takamatsu, K. Shizume, T. Tsushima, 1984, Endocrinologia Japonica.

Detection of Pneumocystis carinii, Mycobacterium tuberculosis, and cytomegalovirus in human immunodeficiency virus (HIV)-infected patients with hemophilia by polymerase chain reaction of induced sputum samples.

S. Ichiyama, K. Shimokata, J. Takamatsu, 1995, Internal medicine.

Sex Differences in the Relationships Between Electrocardiographic Abnormalities and the Extent of Left Ventricular Hypertrophy by Echocardiography

H. Yamada, A. Noda, Y. Koike, 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Decline in the HIV‐1 Isolation Rate in Japan: A 12‐Year Observation

Y. Nagai, J. Takamatsu, S. Yamazaki, 2000, Microbiology and immunology.

Protein S (PS) is a vitamin K-dependent plasma glycoprotein that acts as a cofactor for activated protein C (APC) in the inactivation of the procoagulant factors Va and Villa (1). PS also directly inhibits fac

H. Saito, J. Takamatsu, Y. Okamoto, 2018 .

Fatal liver failure in haemophiliacs with HIV‐induced immunodeficiency: observation of six patients

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

Serum Hyaluronan as a Marker of Liver Fibrosis in Hemophiliacs with Hepatitis C Virus-Associated Chronic Liver Disease

J. Takamatsu, T. Hayakawa, Y. Katano, 1998, Acta Haematologica.

Prophylactic endoscopic ligation of high-risk oesophageal varices in a cirrhotic patient with severe haemophilia A.

J. Takamatsu, T. Hayakawa, Y. Fukuda, 1998, European journal of gastroenterology & hepatology.

Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report.

A. Nakao, J. Takamatsu, T. Nonami, 1994, Hepato-gastroenterology.

[Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].

H. Mohri, J. Takamatsu, A. Shirahata, 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C.

J. Takamatsu, T. Matsushita, H. Wada, 1992, Journal of Laboratory and Clinical Medicine.

Two novel sequence polymorphisms of the human protein C gene.

J. Takamatsu, H. Saito, K. Yamamoto, 1991, Nucleic acids research.

Successful resection of hepatocellular carcinoma found in a patient with anti-HCV antibody positive hemophilia A.

J. Takamatsu, H. Saito, T. Kamiya, 1992 .

Histocompatibility antigens and alleles in Japanese haemophilia A patients with or without factor VIII antibodies.

J. Takamatsu, H. Saito, M. Shima, 1999, Tissue antigens.

A female hemophilia a combined with hereditary coagulation factor XII deficiency: A case report

J. Takamatsu, T. Matsushita, M. Hamaguchi, 1992, American journal of hematology.

A novel subtype of GB virus C/hepatitis G virus genotype 1 detected uniquely in patients with hemophilia in Japan

K. Hayashi, H. Toyoda, J. Takamatsu, 2003, Journal of medical virology.

Pitavastatin attenuates the upregulation of tissue factor in restraint-stressed mice.

J. Takamatsu, T. Matsushita, K. Yamamoto, 2007, Thrombosis research.

CLINICAL USE OF CRYOPRECIPITATE OR FIBRINOGEN CONCENTRATE TO PREVENT MASSIVE HEMORRHAGE DURING SURGERY

M. Nagino, J. Takamatsu, Y. Ueda, 2010 .

EFFICIENT HEMOSTATIC THERAPY USING FIBRINOGEN PRODUCT IN LIVER TRANSPLANTATION

J. Takamatsu, Y. Fujimoto, Taro Nakamura, 2008 .

Effective treatment for massive bleeding with fibrinogen concentrate or cryoprecipitate

J. Takamatsu, 2010 .

Human ryudocan core protein: molecular cloning and characterization of the cDNA, and chromosomal localization of the gene.

J. Inazawa, J. Takamatsu, R. Rosenberg, 1993, Biochemical and biophysical research communications.

Factor V Inhibitor Found in a Patient with Rheumatoid Arthritis and Double Cancer (Laryngeal Cancer and Early Stomach Cancer)

Koji Yamamoto, J. Takamatsu, H. Saito, 1992 .

Carrier Detection and Prenatal Diagnosis of Hemophilia B Using DNA Polymorphisms of the Factor IX Gene in Japanese Subjects

J. Takamatsu, H. Saito, T. Matsushita, 1996 .

Analysis for antithrombin gene polymorphisms in Japanese subjects and cosegregation studies in families with hereditary antithrombin deficiency.

S. Tsuzuki, J. Takamatsu, I. Sugiura, 1996, Thrombosis Research.

Direct carrier detection in hemophilia B kindreds: use of modified primers (mutagenic primers) for enzymatic amplification of the factor IX gene.

M. Tanimoto, J. Takamatsu, H. Saito, 1991, Thrombosis research.

DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.

M. Tanimoto, J. Takamatsu, H. Saito, 1990, Journal of Laboratory and Clinical Medicine.

Extragenic factor IX gene RFLP is useful for detecting carriers of Japanese hemophilia B.

M. Tanimoto, J. Takamatsu, H. Saito, 1989, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

Recent Advance in Clotting Factor Concentrates

J. Takamatsu, 1995 .

Molecular Evaluation of Endothelial Progenitor Cells in Patients With Ischemic Limbs: Therapeutic Effect by Stem Cell Transplantation

T. Naoe, H. Izawa, K. Komori, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Detection of TT virus DNA in plasma-derived clotting factor concentrates.

J. Takamatsu, Y. Fukuda, Y. Katano, 1999, Blood.

Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo

J. Takamatsu, T. Kojima, Kyosuke Takeshita, 2009, International journal of hematology.

Wa Monoclonal Rheumatoid Factors and Non-hodgkin Lymphoma

K. Hayashi, H. Toyoda, J. Takamatsu, 2022 .

Prevalence of Hepatitis E Virus IgG Antibody in Japanese Patients with Hemophilia

K. Hayashi, H. Goto, T. Honda, 2008, Intervirology.

Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution.

J. Takamatsu, S. Iwanaga, H. Saito, 1990, Thrombosis research.

Immunoglobulin Analysis and Epitope Mapping of F VIII Inhibitor Antibodies Developed in Two Nonhemophilic Patients Determined by Immunoblotting

J. Takamatsu, T. Matsushita, M. Shima, 1991 .

Hepatitis C antibody and posttransfusion hepatitis in hemophiliacs.

J. Takamatsu, K. Ogata, T. Kamiya, 1991 .